ERYTECH annuncia la pubblicazione del suo studio di Fase 2b dell’Eryaspase per il trattamento del carcinoma pancreatico metastatico nell’European Journal of Cancer

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition